Abstract:
We have isolated two flavonoids, centaurein and centaurein-like compound, from B. pilosa extract, and found that they inhibit intracellular bacteria infection. These two compounds can be used solely or combined with bacteriocide. In this invention, we have successful demonstrated that the purified compounds from B. pilosa can modulate T cell function via up-regulation of IFNα and in turn, macrophage activation to elicit protective cellular immunity against Listeria infection. In addition, by combining in vitro T-cell cytokine promoter activity assay and in vivo intrabacterial infection mouse systems we have developed a platform technology for screening potential therapeutics for intracellular pathogens.
Fields of Application:
Immune modulator Antibacterial agent Agent for prevention or treatment of intrabacterial infection
Advantages when compared to the existing technologies:
1.Centaurein from B. pilosa can be served as botanical therapeutics, complementary/alternative medications, health food or food supplement for intracellular bacteria infection. 2.Centaurein from B. pilosa can induce the expression of IFN-α and T-bet specifically thus can be served as reagents for modulation of T cell function. 3. The combination of two technology platforms, i.e., in vitro T-cell cytokine promoter activity assay and in vivo intrabacterial infection mouse systems, in this invention can be used to screen useful compounds as therapeutics for intracellular pathogens.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
IP Status:Issued US 7341752 、US7341752B2、TW pending
